SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Risk of Breast Cancer Relapse Can Linger, University of Texas M. D. Anderson Cancer Center Study
August 13, 2008
 · 
1 min read
Bio NC
‘Lost Tribe’ Of Clinician-scientists: Medical Doctors Who Do Research Could Be A Dying Breed
August 12, 2008
 · 
1 min read
Lone Star Bio
New Therapy Freezes Out Esophageal Cancers; Cryoablation Attractive Option For Older Patients With Other Medical Issues, University of Texas Southwestern Medical Center Team Says
August 11, 2008
 · 
1 min read
Lone Star Bio
New Medical Device Makes it Easier for Houston Orthopedic Surgeon to Diagnose ACL Injuries. Sanders Clinic for Orthopedic Surgery and Sports Medicine Using TELOS Stress Device
August 7, 2008
 · 
1 min read
Lone Star Bio
Gold Nanoshells Help Visibly Heat And Destroy Cancer, University of Texas M. D. Anderson Cancer Center and Nanospectra Biosciences, Inc. Study
August 6, 2008
 · 
1 min read
Lone Star Bio
Laser Therapy as Good as Drugs for Diabetic Eye Problems Says Methodist Hospital System in Houston
August 6, 2008
 · 
1 min read
Drug Development
Turned-off Cannabinoid Receptor Turns On Colorectal Tumor Growth, University of Texas M. D. Anderson Cancer Center Study
August 4, 2008
 · 
1 min read
Lone Star Bio
University of Texas Southwestern Medical Center Digestive Specialists Freeze Out Esophagus Cancer With New Therapy
July 30, 2008
 · 
1 min read
Biotech Beach
The Next Generation Life Sciences Leader: The “F” Factors Necessary to Compete
July 28, 2008
 · 
6 min read
Lone Star Bio
Baylor College of Medicine and University of Texas-Houston Medical School Researchers Find Autoantibodies That Block Potentially Fatal Pregnancy Complication
July 28, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Load More